- Latest weekly return ranks in the strongest part of its sector group.
MLC
ISE
Week ended 07 Aug 2026
Weekly Investor Report
Malin Corporation plc · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
7.00 EUR
-1.4%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -7.9% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned -1.4%, after a -3.4% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
21
out of 100
Latest Close
7.00 EUR
7 Aug 2026
1W Return
-1.4%
latest completed week
4W Return
-3.4%
short-term follow-through
12W Return
-6.0%
quarterly tape
Trend Breadth
0.0%
0 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-1.4%
Latest completed week; four-week move -3.4%.
Indicator stack
0/27
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 34.16%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -7.9% below the Trend Line and sits at 0.0% of its 52-week range. The latest completed week returned -1.4%, after a -3.4% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0312-week average 0.06
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure3/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -3.4% over four weeks, -6.0% over 12 weeks, and -14.6% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year0
Trend breadth0.0%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.18Latest activity-pressure read.
Pressure change-20.2%Four-week change in activity pressure.
Leadership-21.36Latest relative-leadership reading.
RS change-17.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-24.7%Distance below the 52-week high.
13-week volatility2.7%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher7 of 2612 weeks finished lower.
Best week+4.2%Week of 26 Jun.
Worst week-6.9%Week of 15 May.
Latest week-1.4%Week of 7 Aug.
Shape of recent returns
Strong gains1
Modest gains6
Flat weeks7
Modest losses11
Sharp losses1
Recent vol2.7%13-week weekly-return volatility.
Base vol2.2%52-week weekly-return volatility.
Up/down split12/21Count of positive and negative weeks in the 52-week window.
Average skew2.5% / -2.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorIE Healthcare
4-week rank1 / 2
Group average-5.5%
Trend breadth50.0%
Trend50.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
IndustryIE Drug Manufacturers - Specialty & Generic
4-week rank1 / 1
Group average-3.4%
Trend breadth0.0%
Trend0.0%active weekly trend signals
MD0.0%positive activity pressure
RS0.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape18/100
Trend, activity pressure, participation, and risk combine to a 18/100 tape read.
Indicator analysis14/100Latest 12-week confirmation: trend 0/12, activity pressure 3/12, relative leadership 0/12.
Activity pressure 0.03; No reversal markers Next-Week ExpectancyNegative 34.16%Next-week expectancy is negative with a 34.16% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Malin Corporation plc (MLC.IR) stock price, news, quote and history Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 7.00 EUR | -1.4% | 7.60 EUR | 7.01 EUR | -1.18 | -21.36 | 292 | Off |
| 31 Jul 2026 | 7.10 EUR | 0.0% | 7.63 EUR | 6.99 EUR | -1.12 | -16.20 | 1 | Off |
| 24 Jul 2026 | 7.10 EUR | -1.4% | 7.65 EUR | 6.97 EUR | -1.07 | -17.04 | 83 | Off |
| 17 Jul 2026 | 7.20 EUR | -0.7% | 7.67 EUR | 6.96 EUR | -0.94 | -16.28 | 70 | Off |
| 10 Jul 2026 | 7.25 EUR | 0.0% | 7.69 EUR | 6.94 EUR | -0.99 | -18.14 | 0 | Off |
| 3 Jul 2026 | 7.25 EUR | -2.7% | 7.71 EUR | 6.93 EUR | -0.97 | -18.91 | 0 | Off |
| 26 Jun 2026 | 7.45 EUR | 4.2% | 7.72 EUR | 6.91 EUR | -0.74 | -17.20 | 0 | Off |
| 19 Jun 2026 | 7.15 EUR | -2.1% | 7.74 EUR | 6.89 EUR | -0.34 | -20.05 | 51 | Off |
| 12 Jun 2026 | 7.30 EUR | -3.9% | 7.77 EUR | 6.88 EUR | -0.05 | -17.07 | 66 | Off |
| 5 Jun 2026 | 7.60 EUR | -1.9% | 7.81 EUR | 6.86 EUR | 0.18 | -11.66 | 0 | Off |
| 29 May 2026 | 7.75 EUR | 2.0% | 7.83 EUR | 6.85 EUR | 0.47 | -10.90 | 3.5K | Off |
| 22 May 2026 | 7.60 EUR | 2.0% | 7.85 EUR | 6.82 EUR | 0.51 | -11.61 | 132 | Off |
| 15 May 2026 | 7.45 EUR | -6.9% | 7.87 EUR | 6.81 EUR | 0.74 | -9.58 | 5.1K | Off |
| 8 May 2026 | 8.00 EUR | 0.6% | 7.91 EUR | 6.79 EUR | 0.97 | -5.83 | 349 | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.